Renee D. Gala - 30 Jun 2026 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Reporting relationship: President & CEO
Issuer ticker: JAZZ
Reported as of: 30 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Jul 2026, 18:21:34 UTC
Prior SEC filing: 05 Jun 2026
Source filing: View source filing
Reporting owner signature: By: /s/Paz Dizon, as attorney in fact For: Renee D. Gala

Key filing fact

Renee D. Gala filed Form 4 for Jazz Pharmaceuticals plc (JAZZ) on 02 Jul 2026.

Key facts

This page summarizes Renee D. Gala's Form 4 filing for Jazz Pharmaceuticals plc (JAZZ).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Jul 2026, 18:21.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

CIK 0001607737 Primary reporting owner

Shares, units, or other non-derivative securities reported in this filing.

JAZZ transaction

Tax liability

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Explanation of responses 1 footnote

Footnote F1

Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.